Presentation is loading. Please wait.

Presentation is loading. Please wait.

Increased apoptotic levels after combined treatment with DXR and imatinib. Increased apoptotic levels after combined treatment with DXR and imatinib. A–D.

Published bySofie Christiansen Modified over 5 years ago

Similar presentations

Presentation on theme: "Increased apoptotic levels after combined treatment with DXR and imatinib. Increased apoptotic levels after combined treatment with DXR and imatinib. A–D."— Presentation transcript:

1 Increased apoptotic levels after combined treatment with DXR and imatinib.
Increased apoptotic levels after combined treatment with DXR and imatinib. A–D represent significant flow cytometry experiments analyzing Annexin-V-FITC detection. Histograms showing Annexin-V and propidium iodide distribution in presence of FBS (A), 10 μm imatinib (B), and imatinib with doxorubicin (DXR; C) are shown in the top half of the figure. The number of A673 early apoptotic cells (Annexin-V +, propidium iodide −) increased when combined treatment was administered (48%) with respect to DXR alone (33%). D shows curve displacement of imatinib + DXR with respect to DXR alone. Iranzu González et al. Clin Cancer Res 2004;10: ©2004 by American Association for Cancer Research

Download ppt "Increased apoptotic levels after combined treatment with DXR and imatinib. Increased apoptotic levels after combined treatment with DXR and imatinib. A–D."

Similar presentations

Incomplete Treatment Complete Treatment Control Flow Cytometric Cell Cycple Analysis of Propidium Iodide-Stained HPAC Cells ControlComplete TreatmentIncomplete.

Incomplete Treatment Complete Treatment Control Flow Cytometric Cell Cycple Analysis of Propidium Iodide-Stained HPAC Cells ControlComplete TreatmentIncomplete.
The expression and signaling of FGFR3 in WM cells.

The expression and signaling of FGFR3 in WM cells.
Supplementary Figure 1 Sensitive Resistant Cell Count Propidium Iodide

Supplementary Figure 1 Sensitive Resistant Cell Count Propidium Iodide
Figure 5. FK866 caused apoptosis in MCF-7 cells while nicotinamide adenine dinucleotide (NAD+) reversed FK866-induced apoptosis. (A) Representative quadrant.

Figure 5. FK866 caused apoptosis in MCF-7 cells while nicotinamide adenine dinucleotide (NAD+) reversed FK866-induced apoptosis. (A) Representative quadrant.
DNA content flow cytometric histograms of propidium iodide–stained A549 cells. DNA content flow cytometric histograms of propidium iodide–stained A549.

DNA content flow cytometric histograms of propidium iodide–stained A549 cells. DNA content flow cytometric histograms of propidium iodide–stained A549.
Targeting the PARP DNA repair pathway enhanced cytotoxicity induced by chemotherapy. Targeting the PARP DNA repair pathway enhanced cytotoxicity induced.

Targeting the PARP DNA repair pathway enhanced cytotoxicity induced by chemotherapy. Targeting the PARP DNA repair pathway enhanced cytotoxicity induced.
IDH1 mutant glioma cells are sensitive to TMZ

IDH1 mutant glioma cells are sensitive to TMZ
Figure 1. Artemisinin derivatives inhibited EOC growth and arrested the cell cycle at the G2/M phase (A) SKOV3 and primary epithelial ovarian cancer (EOC)

Figure 1. Artemisinin derivatives inhibited EOC growth and arrested the cell cycle at the G2/M phase (A) SKOV3 and primary epithelial ovarian cancer (EOC)
(a) (b) SUPPLEMENTARY FIGURE 1:

(a) (b) SUPPLEMENTARY FIGURE 1:
Fas ligand+ fallopian tube epithelium induces apoptosis in both Fas receptor+ T lymphocytes and endometrial cells  Sebastian E. Illanes, M.D., Kevin Maisey,

Fas ligand+ fallopian tube epithelium induces apoptosis in both Fas receptor+ T lymphocytes and endometrial cells  Sebastian E. Illanes, M.D., Kevin Maisey,
FLC treatment results in an increase in ploidy in a significant fraction of cells. FLC treatment results in an increase in ploidy in a significant fraction.

FLC treatment results in an increase in ploidy in a significant fraction of cells. FLC treatment results in an increase in ploidy in a significant fraction.
Valproic acid (VPA) synergises with VAC (mafosfamide, doxorubicin and vindesine) to induce apoptosis in small cell lung carcinoma (SCLC) cell lines. Valproic.

Valproic acid (VPA) synergises with VAC (mafosfamide, doxorubicin and vindesine) to induce apoptosis in small cell lung carcinoma (SCLC) cell lines. Valproic.
Effect of expression of constitutively active CAMKK2 on AMPK activation and the cell cycle in G361 cells. Effect of expression of constitutively active.

Effect of expression of constitutively active CAMKK2 on AMPK activation and the cell cycle in G361 cells. Effect of expression of constitutively active.
Confirmation of synergy and cytotoxicity of genotype-selective drug pairs. Confirmation of synergy and cytotoxicity of genotype-selective drug pairs. A,

Confirmation of synergy and cytotoxicity of genotype-selective drug pairs. Confirmation of synergy and cytotoxicity of genotype-selective drug pairs. A,
CD8+ T cells were immunomodulated and required for the efficacy of anti–4-1BB/anti–PD-1 combination treatment. CD8+ T cells were immunomodulated and required.

CD8+ T cells were immunomodulated and required for the efficacy of anti–4-1BB/anti–PD-1 combination treatment. CD8+ T cells were immunomodulated and required.
MI-773 reduces the fraction of CSCs and prevents recurrence in ACC xenograft tumors. MI-773 reduces the fraction of CSCs and prevents recurrence in ACC.

MI-773 reduces the fraction of CSCs and prevents recurrence in ACC xenograft tumors. MI-773 reduces the fraction of CSCs and prevents recurrence in ACC.
Fig. 5. Combination of SAHA and ML-60218 produces augmented suppression of cellular proliferation with impaired cell cycle progression, enhanced apoptotic.

Fig. 5. Combination of SAHA and ML produces augmented suppression of cellular proliferation with impaired cell cycle progression, enhanced apoptotic.
Apoptosis induced by ssHHT in HL60 and its derivative, the HL60/MRP, cells. Apoptosis induced by ssHHT in HL60 and its derivative, the HL60/MRP, cells.

Apoptosis induced by ssHHT in HL60 and its derivative, the HL60/MRP, cells. Apoptosis induced by ssHHT in HL60 and its derivative, the HL60/MRP, cells.
CYP1A1 knockdown increases cell death.

CYP1A1 knockdown increases cell death.
Figure 1. Effects of Gal-4 on apoptosis and proliferation of monocytes

Figure 1. Effects of Gal-4 on apoptosis and proliferation of monocytes

Similar presentations

Ads by Google